Global and United States Next-Generation Sequencing Market Report & Forecast 2022-2028

Market Analysis and Insights: Global and United States Next-Generation Sequencing Market
This report focuses on global and United States Next-Generation Sequencing market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Next-Generation Sequencing market size is estimated to be worth US$ 8130.6 million in 2022 and is forecast to a readjusted size of US$ 20800 million by 2028 with a CAGR of 17.0% during the review period. Fully considering the economic change by this health crisis, by Type, Targeted Sequencing & Resequencing accounting for % of the Next-Generation Sequencing global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Oncology was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Next-Generation Sequencing market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global Next-Generation Sequencing Scope and Market Size
Next-Generation Sequencing market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Next-Generation Sequencing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Next-Generation Sequencing market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type
Targeted Sequencing & Resequencing
Whole Genome Sequencing
Whole Exome Sequencing
Segment by Application
Oncology
Hereditary Disease Detection
Life Science
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
BGI
Illumina
Perkinelmer
Eurofins Scientific
Gatc Biotech
Macrogen
Qiagen
Genotypic Technology
Genewiz
Dna Link
Takara
Scigenom Labs
Novogene
Personalis